Laparoscopic gastrectomy for gastric cancer: A single cancer center experience
Amr Abouzid
, Ahmed Setit, Ahmed Abdallah, Mohamed Abd Elghaffar, Mosab Shetiwy, Islam A. Elzahaby
Department of Surgical Oncology, Oncology Center, Mansoura University, Mansoura, Egypt
Abstract
Objective: Laparoscopic gastrectomy (LG) was challenging to most surgeons due to the two-dimensional view, difficult manipulations of the instruments, ergonomic discomfort, and the associated muscular spasm and effort. Technological advances with improved surgical experience, have made LG a more feasible and favorable approach for gastric cancer (GC) patients.
Material and Methods: LG was performed in 44 patients with GC between July 2015 to June 2022, in the Department of Surgical Oncology, Oncology Center, Mansoura University, Egypt, and we assessed the surgical outcomes of this approach as an initial experience of a single cancer center.
Results: Twenty-seven patients underwent laparoscopic distal gastrectomy, and seventeen underwent laparoscopic total gastrectomy. Two cases had combined resection. Operative time was 339.2 ± 76.73 min, while blood loss was 153.86 ± 57.51 mL. The patients were ambulant on postoperative day 0, oral intake was started within three days (range 1-5 days) and the hospital stay was six days (range 3-9 days).
Conclusion: LG for GC is a feasible approach for both early and advanced GC patients as it allows for adequate diagnosis of the peritoneal disease, meticulous dissection, and identification of the lymph nodes with minimal blood loss and decrease surgery-related problems and encourage the early patients’ discharge from hospital and return to daily life activities.
Keywords: Laparoscopic gastrectomy, gastric cancer, minimally invasive surgery
Cite this article as: Abouzid A, Setit A, Abdallah A, Elghaffar MA, Shetiwy M, Elzahaby IA. Laparoscopic gastrectomy for gastric cancer: A single cancer center experience. Turk J Surg 2023; 39 (4): 354-364.
This study was approved by the Institutional Review Board (IRB) of the Faculty of Medicine, Mansoura University with a code number (R.22.02.1613). A written informed consent was signed by all the patients before inclusion in this study.
Externally peer-reviewed.
Concept - AA, AS, AA; Design - AA, AS; Supervision - AA, AS, MS; Data Collection and/ or Processing - AA, IAE, MS, MAE, AA; Analysis and/or Interpretation - AA, AS, MS, AA; Literature Search - AA; Writing Manuscript - AA; Critical Reviews - All of authors.
The authors have no conflicts of interest to declare.
The authors declared that this study has received no financial support.